everything you want to know (and don't) about arkansas politics

Republican Sponsorship
Healthcare

SB143

To Amend The Prior Authorization Transparency Act; And To Exempt Certain Healthcare Providers That Provide Certain Healthcare Services From Prior Authorization Requirements.

Introduced

Last Action (Jan. 26, 2023): Sine Die adjournment

Sponsors

AI-Generated Summary

Senate Bill 143 seeks to amend the Prior Authorization Transparency Act in Arkansas to reduce the administrative burden of prior authorization requirements for healthcare providers. The bill establishes a process for exempting healthcare providers from prior authorization for specific services if the provider maintains a 90% or higher approval rate for those services over a designated evaluation period. It sets forth specific criteria for determining eligibility for this exemption, including a trial period starting January 1, 2024, and provides a mechanism for insurers to rescind the exemption if a provider's performance falls below defined thresholds. Additionally, the bill mandates that adverse determinations regarding prior authorizations must be made by a licensed physician and requires utilization review entities to provide opportunities for peer-to-peer discussions. It also clarifies reporting requirements for insurers to ensure transparency in how they evaluate provider performance and determine exemptions. The legislation aims to streamline patient access to care by allowing high-performing providers to bypass typical authorization delays.

Potential Impact Analysis

Who Might Benefit?

The primary beneficiaries of this bill are healthcare providers, particularly those with high rates of prior authorization approval, as they would face less administrative burden and more autonomy in their clinical decision-making. Patients also stand to benefit, as reduced bureaucratic hurdles for their providers could lead to faster access to treatments, tests, and medical services that currently require prior authorization.

Who Might Suffer?

Healthcare insurers and utilization review entities would be the primary entities negatively impacted, as they would be required to implement new evaluation processes, manage the exemption program, and potentially face increased costs associated with administrative oversight and compliance. These entities may also experience a reduction in their ability to perform traditional utilization management, which they often use to control healthcare expenditures and monitor service necessity.

Read Full Bill on arkleg.state.ar.us